Table 3. Predictors of death or intubation: Final models.

Variable	HR (95%CI)	p
WHOLE COHORT (n = 242)
Week-2-MP	0.33 (0.13–0.84)	0.020
Non-pulse glucocorticoids	3.87 (1.87–8.02)	<0.001
SpO2/FiO2	0.92 (0.89–0.94)	<0.001
CURB65
Low risk	Reference
Intermediate risk	1.93 (0.83–4.45)	0.125
High risk	3.65 (1.48–9.02)	0.005
PATIENTS WITH SatO2/FiO2 ≤353 (n = 122)
Week-2-MP	0.34 (0.12–0.94)	0.038
Non-pulse glucocorticoids	3.16 (1.36–7.37)	0.008
SpO2/FiO2*	0.88 (0.83-0-93)	<0.001
CURB65
Low risk	Reference
Intermediate risk	1.78 (0.69–4.57)	0.234
High risk	3.94 (1.44–10.78)	0.008

Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*HR for SpO2/FiO2 is change in hazard for each increase of 10 units in its value.